Jeffrey Kappler Biography and Net Worth

SVP of Envista

As SVP & President of Ormco, Jeff Kappler leads the team that creates confidence worldwide through innovative, high-quality orthodontic solutions.

Jeff originally joined Danaher in 2007 as a Factory Manager and Operations Leader. He then served as Global Product Manager and Business Unit Manager for Veeder-Root, then a Danaher operating company, for three years. Jeff joined KaVo Kerr in 2015 and held multiple global leadership roles across Danaher’s Dental Platform. He was named President of Ormco in September 2018.

Prior to Danaher, Jeff was a Captain in the U.S. Marine Corps. He holds a BA in International Studies from Dickinson College and an MBA from the University of Virginia. He lives in Memphis, Tennessee, with his wife and four children.

What is Jeffrey Kappler's net worth?: The estimated net worth of Jeffrey Kappler is at least $723,710.00 as of August 4th, 2021. Mr. Kappler owns 38,090 shares of Envista stock worth more than $723,710 as of December 18th. This net worth approximation does not reflect any other investments that Mr. Kappler may own. Learn More about Jeffrey Kappler's net worth.
How do I contact Jeffrey Kappler?: The corporate mailing address for Mr. Kappler and other Envista executives is 200 S. KRAEMER BLVD. BUILDING E, BREA CA, 92821. Envista can also be reached via phone at 714-817-7000 and via email at [email protected]. Learn More on Jeffrey Kappler's contact information.
Has Jeffrey Kappler been buying or selling shares of Envista?: Jeffrey Kappler has not been actively trading shares of Envista during the past quarter. Most recently, Jeffrey Kappler sold 153 shares of the business's stock in a transaction on Wednesday, November 17th. The shares were sold at an average price of $42.30, for a transaction totalling $6,471.90. Learn More on Jeffrey Kappler's trading history.
Who are Envista's active insiders?: Envista's insider roster includes Amir Aghdaei (CEO), Curt Bludworth (Insider), Eric Conley (SVP), Eric Hammes (CFO), Jeffrey Kappler (SVP), Stephen Keller (Principal Financial Officer), Mark Nance (General Counsel), Mischa Reis (SVP), and Howard Yu (CFO). Learn More on Envista's active insiders.
Are insiders buying or selling shares of Envista?: During the last twelve months, Envista insiders bought shares 1 times. They purchased a total of 24,532 shares worth more than $400,607.56. The most recent insider tranaction occured on August, 12th when CFO Eric D Hammes bought 24,532 shares worth more than $400,607.56. Insiders at Envista own 1.3% of the company. Learn More about insider trades at Envista.
Information on this page was last updated on 8/12/2024.

Jeffrey Kappler Insider Trading History at Envista

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2021	Sell	153	$42.30	$6,471.90
11/15/2021	Sell	511	$43.20	$22,075.20
8/4/2021	Sell	47	$44.25	$2,079.75	38,090
7/16/2021	Sell	1,717	$42.00	$72,114.00
4/7/2021	Sell	13,473	$44.95	$605,611.35	45,578
3/29/2021	Sell	13,971	$41.25	$576,303.75	40,530
3/26/2021	Sell	4,579	$40.72	$186,456.88	40,530

Jeffrey Kappler Buying and Selling Activity at Envista

Envista Company Overview

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

Today's Range

Now: $19.00

$18.85

$19.26

50 Day Range

MA: $20.12

$17.70

$22.33

2 Week Range

Now: $19.00

$15.15

$25.64

Volume

135,210 shs

Average Volume

2,355,810 shs

Market Capitalization

$3.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.31

DeFi Coin on Verge of Breakout!

From Crypto 101 Media | Ad

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!